CXCL12 and ovarian carcinoma: In addition to driving hematopoietic cells as well as breast and prostate cancer cells to the bone [186,187,188,189], CXCR4/SDF-1α signaling has also been shown to promote ovarian cancer metastasis and is a predictor of poor prognosis in ovarian cancer [190,191].